FindTrial
Sign In

Role of measuring blood supply of eye with other biophysical markers at 19-24 weeks in detecting development of high blood pressure in pregnancy

Role of Ophthalmic Artery Doppler in prediction of pre-eclampsia with biophysical markers at 19-24 weeks gestation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037200
Enrollment
575
Registered
2021-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

None listed

Sponsors

Fernandez Hospital Foundation
Lead Sponsor
Fernandez Hospital Foundation
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: •All singleton mothers booked before 24 weeks •Mothers who birth at Fernandez Hospital •Singleton pregnancies with structurally normal fetus between 19-24 weeks •Population who are unscreened for preeclampsia in first trimester

Exclusion criteria

Exclusion criteria: 1.Pregnancies with aneuploidy and major fetal abnormality 2.Multifetal pregnancy 3.Miscarriage or fetal death before 26 weeks 3.Loss to follow up 4.Screened for pre-eclampsia in first trimester 5.Mothers with renal disease causing hypertension and proteinuria 6.Mothers with ocular/ ophthalmic artery pathologies using vasodilating drug

Design outcomes

Primary

MeasureTime frame
To predict preterm PE (37 weeks) and term PE (â?¥37weeks) using Opthalmic artery doppler Timepoint: After delivery and discharge from the hospital.—

Secondary

MeasureTime frame
Preterm and term delivery and development of pre-eclampsia using Ophthalmic artery doppler, Uterine artery PI, mean arterial pressure.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Tseten Zangmu Bhutia

Fernandez foundation

drsuseela@gmail.com7005456277

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026